Data as of Sep 30
| -0.51 / -0.71%|
The 30 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 69.69, with a high estimate of 94.22 and a low estimate of 48.00. The median estimate represents a -2.45% decrease from the last price of 71.44.
The current consensus among 32 polled investment analysts is to Hold stock in AstraZeneca PLC. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.